News

University of Miami Health System Starts Clinical Trial to Test Regenerative Treatment for Stroke

The University of Miami Health System is starting a clinical trial to further evaluate the safety and efficacy of an investigational cell therapy for the treatment of chronic motor deficit following an ischemic stroke.

Read more about the stroke research »

AML cells under the microscope. Source: The website of the National Cancer Institute (https://www.cancer.gov).

Researchers show p300 protein may suppress leukemia in MDS patients

Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that p300, a protein that increases gene expression by attaching acetyl molecules to DNA, may stop myelodysplastic syndrome (MDS) from developing into acute myeloid leukemia (AML). The study was published in the journal Leukemia.

Read more about the leukemia research »

Clockwise from top left, Glen Barber, Ph.D., Ph.D. student Dillon Betancourt, Jeonghyun Ahn, Ph.D., Ph.D. student Nina de Queiroz, and Tianli Xia, Ph.D.

Miller School Researchers Move Forward with Development of Zika Vaccine

Following early-stage development of a vaccine to protect against the Zika virus, a group of researchers at the University of Miami Miller School of Medicine has published its initial findings. Now, with new funding, they are moving forward with non-human primate testing and, eventually, phase I human trials.

Read more about the Zika vaccine research »

Clockwise from top left, Unzila Nayeri, M.D., Michael E. Ivan, M.D., neurosurgery resident Roberto Perez Roman, M.D., Maria Emilse Munoz Pena with baby Santino Michar Pena, and father Michar Pena.

UHealth Surgeons at Jackson Remove Two Brain Tumors from Pregnant Woman

A Florida mother is thanking University of Miami Health System doctors after they removed two benign brain tumors strangling her optic nerves and restored her sight – all while she was six months pregnant.

Read more about the surgery »

The top images show the untreated retina, left, and the effect of anti-Scg-3 therapy to treat retinopathy of prematurity in a mouse model. The bottom images zoom in on the blood vessels.

Study Suggests New Way to Prevent Vision Loss in Diabetics and Premature Babies

Researchers at Bascom Palmer Eye Institute, part of the University of Miami Miller School of Medicine, have identified a new molecule that induces the formation of abnormal blood vessels in the eyes of diabetic mice. The study suggests that inhibiting this molecule may prevent similarly aberrant blood vessels from damaging the vision of not only diabetics, but also premature infants.

Read more about Dr. Li's study »

News Archives

Office of the Dean

A message from the dean

Med

Read Med

e-Update

Read e-Update